Physiomics plc has this week announced it has been awarded a further contract by existing client Ankyra Therapeutics and it is participating in the 37th Annual Meeting of the Society for Immunotherapy of Cancer. We have published research on this which is attached and a snapshot of the research is below.
In pursuit of growth, Physiomics is broadening its presence in Europe and North America. The participation in the Society for Immunotherapy of Cancer (SITC) conference this week in Boston, the ....
10 Nov 2022
Hybridan Research: 10/11/2022: Physiomics plc: Further steps along the way to growth
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Hybridan Research: 10/11/2022: Physiomics plc: Further steps along the way to growth
Physiomics Plc (PYC:LON) | 1.3 0 13.0% | Mkt Cap: 1.76m
- Published:
10 Nov 2022 -
Author:
Emily Liu -
Pages:
7
Physiomics plc has this week announced it has been awarded a further contract by existing client Ankyra Therapeutics and it is participating in the 37th Annual Meeting of the Society for Immunotherapy of Cancer. We have published research on this which is attached and a snapshot of the research is below.
In pursuit of growth, Physiomics is broadening its presence in Europe and North America. The participation in the Society for Immunotherapy of Cancer (SITC) conference this week in Boston, the ....